PROXYCAM TAB is an advanced non-steroidal anti-inflammatory drug (NSAID) that features Etoricoxib as its active pharmaceutical ingredient. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, developed to provide effective pain relief and inflammation reduction with a significantly reduced risk of gastrointestinal irritation compared to traditional non-selective NSAIDs.

This medication is widely indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, chronic musculoskeletal pain, and postoperative dental pain. It provides targeted relief by blocking the COX-2 enzyme, which plays a critical role in the production of prostaglandins responsible for pain and inflammation. Unlike non-selective NSAIDs, Etoricoxib in PROXYCAM TAB spares the COX-1 enzyme, preserving gastric mucosa and reducing the risk of peptic ulcers and gastrointestinal bleeding.

In the management of osteoarthritis and rheumatoid arthritis, PROXYCAM TAB helps relieve joint stiffness, swelling, and pain, improving mobility and quality of life for patients with chronic inflammatory conditions. For acute gouty arthritis and ankylosing spondylitis, it provides rapid onset of pain relief and inflammation control, making it suitable for both short-term flare-ups and long-term treatment plans.

Typically administered in doses ranging from 60 mg to 120 mg once daily (depending on indication and patient response), PROXYCAM TAB provides convenience and efficacy with its once-a-day dosing regimen. The tablet exhibits high oral bioavailability and demonstrates peak plasma levels within an hour of ingestion, offering quick symptom relief.

While Etoricoxib is generally well tolerated, it must be used cautiously in patients with pre-existing cardiovascular disease, renal impairment, or liver dysfunction. Common side effects may include headache, dizziness, hypertension, and fluid retention. It is contraindicated in patients with active peptic ulceration, inflammatory bowel disease, severe hepatic or renal impairment, and in pregnant or breastfeeding women.

Bluepill Express ensures that each batch of PROXYCAM TAB is manufactured in WHO-GMP and ISO-certified facilities, adhering to international quality control standards. Every product undergoes rigorous testing for purity, stability, and bioequivalence, and comes with a detailed certificate of analysis (COA) and regulatory support documentation to facilitate smooth approvals in regulated and semi-regulated markets.

We offer PROXYCAM TAB in a variety of dosage strengths and packaging formats based on client specifications. Whether it is bulk packaging for institutional procurement, customized branding for private label projects, or regulated market submissions, Bluepill Express provides scalable and flexible third-party manufacturing solutions.

Our extensive export network covers over 140 countries including the USA, UK, South Africa, Australia, Latin America, and Southeast Asia. PROXYCAM TAB is part of our core NSAID and chronic pain management portfolio, showcasing Bluepill Express’s strength in anti-inflammatory and analgesic drug production with an emphasis on innovation, affordability, and safety.